669 related articles for article (PubMed ID: 25691639)
1. Avibactam and inhibitor-resistant SHV β-lactamases.
Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
[TBL] [Abstract][Full Text] [Related]
2. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
[TBL] [Abstract][Full Text] [Related]
3. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
Winkler ML; Papp-Wallace KM; Bonomo RA
J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
[TBL] [Abstract][Full Text] [Related]
4. Reclaiming the efficacy of β-lactam-β-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidime.
Papp-Wallace KM; Winkler ML; Gatta JA; Taracila MA; Chilakala S; Xu Y; Johnson JK; Bonomo RA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4290-7. PubMed ID: 24820081
[TBL] [Abstract][Full Text] [Related]
5. Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.
Barnes MD; Taracila MA; Good CE; Bajaksouzian S; Rojas LJ; van Duin D; Kreiswirth BN; Jacobs MR; Haldimann A; Papp-Wallace KM; Bonomo RA
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182530
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain.
Giani T; Cannatelli A; Di Pilato V; Testa R; Nichols WW; Rossolini GM
Diagn Microbiol Infect Dis; 2016 Sep; 86(1):83-5. PubMed ID: 27394638
[TBL] [Abstract][Full Text] [Related]
7. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.
Papp-Wallace KM; Bajaksouzian S; Abdelhamed AM; Foster AN; Winkler ML; Gatta JA; Nichols WW; Testa R; Bonomo RA; Jacobs MR
Diagn Microbiol Infect Dis; 2015 May; 82(1):65-9. PubMed ID: 25737290
[TBL] [Abstract][Full Text] [Related]
8. Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations.
Lahiri SD; Bradford PA; Nichols WW; Alm RA
J Antimicrob Chemother; 2016 Oct; 71(10):2848-55. PubMed ID: 27402011
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from
Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM
ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985
[No Abstract] [Full Text] [Related]
10. Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study.
Krishnan NP; Nguyen NQ; Papp-Wallace KM; Bonomo RA; van den Akker F
PLoS One; 2015; 10(9):e0136813. PubMed ID: 26340563
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a Ceftazidime-Avibactam combination in a murine model of Septicemia caused by Enterobacteriaceae species producing ampc or extended-spectrum β-lactamases.
Levasseur P; Girard AM; Lavallade L; Miossec C; Pace J; Coleman K
Antimicrob Agents Chemother; 2014 Nov; 58(11):6490-5. PubMed ID: 25136016
[TBL] [Abstract][Full Text] [Related]
12. Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae.
Papp-Wallace KM; Barnes MD; Alsop J; Taracila MA; Bethel CR; Becka SA; van Duin D; Kreiswirth BN; Kaye KS; Bonomo RA
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610205
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Landscape of Diazabicyclooctane (DBO) Inhibition: Avibactam Inactivation of PER-2 β-Lactamase.
Ruggiero M; Papp-Wallace KM; Taracila MA; Mojica MF; Bethel CR; Rudin SD; Zeiser ET; Gutkind G; Bonomo RA; Power P
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348157
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases.
Levasseur P; Girard AM; Miossec C; Pace J; Coleman K
Antimicrob Agents Chemother; 2015 Apr; 59(4):1931-4. PubMed ID: 25583732
[TBL] [Abstract][Full Text] [Related]
15. Structural Insights into the Inhibition of the Extended-Spectrum β-Lactamase PER-2 by Avibactam.
Ruggiero M; Papp-Wallace KM; Brunetti F; Barnes MD; Bonomo RA; Gutkind G; Klinke S; Power P
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235626
[TBL] [Abstract][Full Text] [Related]
16. The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection.
MacGowan A; Tomaselli S; Noel A; Bowker K
J Antimicrob Chemother; 2017 Mar; 72(3):762-769. PubMed ID: 28039276
[TBL] [Abstract][Full Text] [Related]
17. Molecular Basis of Class A β-Lactamase Inhibition by Relebactam.
Tooke CL; Hinchliffe P; Lang PA; Mulholland AJ; Brem J; Schofield CJ; Spencer J
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383664
[TBL] [Abstract][Full Text] [Related]
18. Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibition.
Sulton D; Pagan-Rodriguez D; Zhou X; Liu Y; Hujer AM; Bethel CR; Helfand MS; Thomson JM; Anderson VE; Buynak JD; Ng LM; Bonomo RA
J Biol Chem; 2005 Oct; 280(42):35528-36. PubMed ID: 15987690
[TBL] [Abstract][Full Text] [Related]
19. First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate.
Humphries RM; Yang S; Hemarajata P; Ward KW; Hindler JA; Miller SA; Gregson A
Antimicrob Agents Chemother; 2015 Oct; 59(10):6605-7. PubMed ID: 26195508
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.
Pemberton OA; Noor RE; Kumar M V V; Sanishvili R; Kemp MT; Kearns FL; Woodcock HL; Gelis I; Chen Y
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5818-5825. PubMed ID: 32123084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]